Archives
Redwood Pharma initiates toxicological safety studies
March 15, 2017 12:00 pmRedwood Pharma AB (publ) now begins toxicological safety studies for its drug development project RP101. The results will initially be... View Article
Redwood Pharma inleder toxikologiska säkerhetsstudier för RP101
March 15, 2017 12:00 pmRedwood Pharma AB (publ) inleder nu toxikologiska säkerhetsstudier inom ramen för läkemedelsprojektet RP101. Resultaten ska närmast användas i bolagets ansökan... View Article
Nytt amerikanskt patent: VD Martin Vidaeus berättar
March 7, 2017 12:00 pmNew US patent approved
March 2, 2017 12:00 pmRedwood Pharma’s licensor, Broda Technologies, has been granted an additional patent in the US regarding the IntelliGel drug delivery platform.... View Article
Redwood Pharma AB – End of Year Report 2016
February 15, 2017 12:00 pmRedwood Pharma AB – End of Year Report 2016
February 15, 2017 12:00 pmRedwood Pharma AB (publ) End of Year Report 2016
February 15, 2017 12:00 pmRedwood Pharma AB (publ), End of Year Report 2016 January – December 2016. The period January 1 – December 31,... View Article
Redwood Pharma AB (publ) Bokslutskommuniké 2016
February 15, 2017 12:00 pmRedwood Pharma AB (publ), Bokslutskommuniké 2016 januari – december 2016 Perioden 1 januari – 31 december 2016 • Bolagets nettoomsättning... View Article
Eye expert to support Redwood Pharma
February 13, 2017 12:00 pmIn preparation for the upcoming pharmaceutical clinical trial of RP101, Redwood Pharma AB (publ) has retained Associate Professor Gerhard Garhöfer... View Article